Bench to Bedside S9E7: The latest in brain cancer research and care
Bench to Bedside
English - April 27, 2022 15:30 - 27 minutes - 37.2 MB - ★★★★ - 3 ratingsMedicine Health & Fitness Nutrition cancer healthcare research therapies Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Approximately 89,000 people in the U.S. will receive a primary brain tumor diagnosis this year. And for those with cancerous brain tumors, life as they know it is changing, with most patients living up to five years after their diagnosis. Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, will discuss the latest advances in brain cancer research and treatment with neuro-oncologist Dr. Tolga Tuncer, and Drs. Fen Wang and David Akhavan, who are both radiation oncologists.
Approximately 89,000 people in the U.S. will receive a primary brain tumor diagnosis this year. And for those with cancerous brain tumors, life as they know it is changing, with most patients living up to five years after their diagnosis. Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, will discuss the latest advances in brain cancer research and treatment with neuro-oncologist Dr. Tolga Tuncer, and Drs. Fen Wang and David Akhavan, who are both radiation oncologists.